Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Feasibility and utility of unmatched whole-genome sequencing (uWGS) for pediatric acute leukemias: An analysis of leukemia precision-based therapy (LEAP) study samples

Blood (2025) 146 (Supplement 1): 2561.

https://doi.org/10.1182/blood-2025-2561

Published: 2025

Journal Articles

Age-related differences in presentation among pediatric, adolescent, and young adults with mixed cellularity vs. nodular sclerosis histology Hodgkin lymphoma on Children's oncology group treatment and registry trials

Mallorie Heneghan, Lindsay Renfro, Yue Wu, Angela Feraco, Jamie Flerlage, Boyu Hu, Erin Marcotte, Cindy Schwartz, Kara Kelly, Sharon Castellino, Justine Kahn

Blood (2025) 146 (Supplement 1): 1849.

https://doi.org/10.1182/blood-2025-1849

Published: 2025

Journal Articles

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Melissa Burns, Yael Flamand, Lynda Vrooman, Victoria Koch, Sarah Cronholm, Sarah Hunt, Marian Harris, Peter Cole, Lisa Gennarini, Nobuko Hijiya, Justine Kahn, Kara Kelly, Bruno Michon, Donna Neuberg, Andrew Place, Thai Tran, Jennifer Welch, Stephen Sallan, Lewis Silverman

Blood (2025) 146 (Supplement 1): 644.

https://doi.org/10.1182/blood-2025-644

Published: 2025

Journal Articles

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Blood (2025) 146 (Supplement 1): 710.

https://doi.org/10.1182/blood-2025-710

Published: 2025

Journal Articles

Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium

Sara Mohamed, Yael Flamand, Victoria Koch, Lynda Vrooman, Peter Cole, Lisa Gennarini, Kara Kelly, Bruno Michon, Thai Hoa Tran, Jennifer Welch, Jeffrey Supko, Justine Kahn, Lewis Silverman

Blood (2025) 146 (Supplement 1): 5104.

https://doi.org/10.1182/blood-2025-5104

Published: 2025

Journal Articles

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Blood (2025) 146 (Supplement 1): 4523.

https://doi.org/10.1182/blood-2025-4523

Published: 2025

Journal Articles

Changes in body composition during early phases of treatment and subsequent risk of relapse in childhood Hodgkin lymphoma

Aman Wadhwa, Chen Dai, Omar Ahmen, Sandra Kessel, Joshua Richman, Wei Shen, Justine Kahn, Sharon Castellino, Kara Kelly, Debra Friedman, Smita Bhatia

Blood (2025) 146 (Supplement 1): 156.

https://doi.org/10.1182/blood-2025-156

Published: 2025

Journal Articles

Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.

Jennifer Welch, Yael Flamand, Victoria Koch, Peter Cole, Lisa Gennarini, Justine Kahn, Kara Kelly, Bruno Michon, Thai Hoa Tran, Ilan Kirsch, Heidi Simmons, Melissa Burns, Lewis Silverman, Marian Harris

Blood (2025) 146 (Supplement 1): 5146.

https://doi.org/10.1182/blood-2025-5146

Published: 2025

Journal Articles

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Justine Kahn, MD, Sergio Barrera, Randy Davila, Emily Roberts, ZheZhen Jin, PhD, Kristen Stevenson, MS, Traci M. Blonquist, MS, Donna S Neuberg, ScD, Uma H. Athale, MD, M.Sc., Luis A. Clavell, MD, Peter Cole, MD, Caroline Laverdiere, MD, Bruno Michon, MD FRCPC, Marshall A. Schorin, MD, Jennifer J.G. Welch, MD, Stephen E. Sallan, MD, Lewis B. Silverman, MD, Kara M. Kelly, MD

Blood (2015) 126 (23): 248.

https://doi.org/10.1182/blood.V126.23.248.248

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Feasibility and utility of unmatched whole-genome sequencing (uWGS) for pediatric acute leukemias: An analysis of leukemia precision-based therapy (LEAP) study samples

Age-related differences in presentation among pediatric, adolescent, and young adults with mixed cellularity vs. nodular sclerosis histology Hodgkin lymphoma on Children's oncology group treatment and registry trials

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: A report from the DFCI ALL 16-001 Trial

Associations between serum asparaginase activity and asparaginase-associated toxicities in pediatric ALL patients receiving calaspargase: A report from the DFCI ALL consortium

Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma (PTCL): A multicenter retrospective Study

Changes in body composition during early phases of treatment and subsequent risk of relapse in childhood Hodgkin lymphoma

Comparison of paired bone marrow and peripheral blood measurable residual disease in pediatric acute lymphoblastic leukemia by next-generation sequencing: A report from the dana farber ALL consortium protocol 16-001.

Higher Incidence of Treatment-Related Toxicities in Non-Hispanic Patients Undergoing Therapy for Newly Diagnosed Pediatric Acute Lymphoblastic Leukemia on Dana-Farber Cancer Institute ALL Consortium Protocol 05-001

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only